Mar 31, 2024

Arcturus Therapeutics Q1 2024 Earnings Report

Total Revenue
$38M
Previous year: $80.3M
-52.7%
EPS
-$1
Previous year: $0.62
-261.3%
Research and development
$53.6M
General and administrative
$14.9M
Gross Profit
$38M
Previous year: $80.3M
-52.7%
Cash and Equivalents
$343M
Previous year: $328M
+4.7%
Free Cash Flow
-$5.8M
Previous year: -$36.6M
-84.1%
Total Assets
$419M
Previous year: $471M
-11.0%

Arcturus Therapeutics

Arcturus Therapeutics

Arcturus Therapeutics Revenue by Segment

Revenue & Expenses

Visualization of income flow from segment revenue to net income